Javascript er ikke aktivert i din nettleser. Dette er nødvendig for å bruke Oncolex. Kontakt din systemadministrator for å aktivere JavaScript.

Referanser til nevroendokrine svulster

  1. Boyar Cetinkaya R(1), Aagnes B, Thiis-Evensen E, Tretli S, Bergestuen DS, Hansen S. Trends in Incidence of Neuroendocrine Neoplasms in Norway: A Report of 16,075 Cases from 1993 through 2010.Neuroendocrinology. 2015 Nov 13. DOI: 10.1159/000442207
  2. Cancer in Norway 2015, Cancer Registry of Norway, Institute of Population-based Research. Oslo, Norway

    Årsaker

  3. Toumpananakis CG, Chaplin ME. Molecular genetics of gastroenteropancreatic neuroendocrine tumors. Am J Gastroenterol 2008; 103: 729–32

    Histologi

  4. Hamilton SR, Aaltonen LA. WHO Classification of Tumors. Pathology and Genetics of Tumours of Digestive System. Lyon, France: IARC Press, 2000:204 

    Stadier/Prognose

  5. H. Sorbye; S. Welin; S. W. Langer; L. W. Vestermark; N. Holt; P. Osterlund; S. Dueland; E. Hofsli; M. G. Guren; K. Ohrling; E. Birkemeyer; E. Thiis-Evensen; M. Biagini; H. Gronbaek; L. M. Soveri; I. H. Olsen; B. Federspiel; J. Assmus; E. T. Janson; U. Knigge. Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC studyAnn Oncol 2013 24: 152-160

    Diagnostikk

  6. Taupenot L, Harper KL, O'Connor DT. The chromogranin-secretogranin family. N Engl J Med. 2003; 348: 1134–49
  7. Betchen SA, Cirigliano M, Furth EE et al. Tubulovillous adenoma of the duodenum, a new etiology for flushing and urinary 5-HIAA elevation. DigDisSci 1998; 43: 1447–81

    Kirurgi

  8. van Vilsteren FG, Baskin-Bey ES, Nagorney DM et al. Liver transplantation for gastroenteropancreatic neuroendocrine cancers: Defining selection criteria to improve survival. Liver Transpl. 2006 Mar; 12(3): 448–56

    Medikamentell behandling

  9. Vilar E, Salazar R, Pérez-García J et al. Chemotherapy and role of the proliferation marker Ki-67 in digestive neuroendocrine tumors. Endocr Relat Cancer. 2007; 14: 221–32

    Strålebehandling

  10. Kwekkeboom DJ, de Herder WW, Kam BL et al. Chemotherapy and role of the proliferation marker Ki-67 in digestive neuroendocrine tumors. Endocr Relat Cancer. 2007; 14: 221–32

Internasjonale retningslinjer

Nordiske

Janson ET, Sorbye H, Welin S, Federspiel B, Grønbæk H, Hellman P, Ladekarl M, Langer SW, Mortensen J, Schalin-Jäntti C, Sundin A, Sundlöv A, Thiis-Evensen E, Knigge U. Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms. Acta Oncol. 2014 Oct;53(10):1284-97. doi: 10.3109/0284186X.2014.941999.

Europeiske (ENETS)

Tynntarm/appendix-NET

Pape UF, Perren A, Niederle B, Gross D, Gress T, Costa F, Arnold R, Denecke T, Plöckinger U, Salazar R, Grossman A; Barcelona Consensus Conference participants. ENETS Consensus Guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinomas. Neuroendocrinology. 2012;95(2):135-56. doi: 10.1159/000335629.

Levermetastaser fra NET

Pavel M, Baudin E, Couvelard A, Krenning E, Öberg K, Steinmüller T, Anlauf M,  Wiedenmann B, Salazar R; Barcelona Consensus Conference participants. ENETS Consensus Guidelines for the management of patients with liver and other distant  metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary. Neuroendocrinology. 2012;95(2):157-76. doi: 10.1159/000335597.

Gastroduodenale-NET

Delle Fave G, Kwekkeboom DJ, Van Cutsem E, Rindi G, Kos-Kudla B, Knigge U, Sasano H, Tomassetti P, Salazar R, Ruszniewski P; Barcelona Consensus Conference participants. ENETS Consensus Guidelines for the management of patients with gastroduodenal neoplasms. Neuroendocrinology. 2012;95(2):74-87. doi:10.1159/000335595.

Kolrektale-NET

Caplin M, Sundin A, Nillson O, Baum RP, Klose KJ, Kelestimur F, Plöckinger U, Papotti M, Salazar R, Pascher A; Barcelona Consensus Conference participants. ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: colorectal neuroendocrine neoplasms. Neuroendocrinology. 2012;95(2):88-97. doi: 10.1159/000335594.

Hormonproduserned bukspyttkjertel-NET

Jensen RT, Cadiot G, Brandi ML, de Herder WW, Kaltsas G, Komminoth P, Scoazec JY, Salazar R, Sauvanet A, Kianmanesh R; Barcelona Consensus Conference participants. ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes. Neuroendocrinology. 2012;95(2):98-119. doi: 10.1159/000335591.

Ikke-hormonproduserende bukspyttkjertel-NET

Falconi M, Bartsch DK, Eriksson B, Klöppel G, Lopes JM, O'Connor JM, Salazar R, Taal BG, Vullierme MP, O'Toole D; Barcelona Consensus Conference participants. ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors. Neuroendocrinology. 2012;95(2):120-34. doi:10.1159/000335587.


Prosedyrer i Oncolex kan ikke erstatte faglig veiledning fra kvalifisert veileder. Den som følger prosedyrene har et selvstendig ansvar for at det foreligger nødvendig godkjenning, lisens eller autorisasjon.
Oslo universitetssykehus HF © 2016